Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Bloedow

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical Sciences|March 1, 1976
Effects of lipids on bioavailability of sulfisoxazole acetyl, dicumarol, and griseofulvin in ratsD C Bloedow, W L Hayton
Journal of Pharmaceutical Sciences|March 1, 1976
Saturable first-pass metabolism of sulfisoxazole N1-acetyl in ratsD C Bloedow, W L Hayton
Canadian Journal of Physiology and Pharmacology|August 1, 1979
Ketamine kinetics: decerebrate vs. intact catsJ E Heavner, D C Bloedow
The American Journal of Physiology|October 12, 1999
Pharmacokinetics of insulin-like growth factor I in hypopituitarism: correlation with binding proteinsN Mauras, V Quarmby, D C Bloedow
Research Communications in Chemical Pathology and Pharmacology|October 1, 1982
Serum binding of tocainide and its enantiomers in human subjectsA J Sedman, D C Bloedow, J Gal
Alcoholism, Clinical and Experimental Research|January 1, 1983
Nonlinear pharmacokinetics of ethanol elimination in long sleep and short sleep miceD M Gilliam, D C Bloedow, A C Collins
Journal of Pharmaceutical Sciences|November 1, 1981
Pharmacokinetics of intravenous chlorpheniramine in childrenJ A Thompson, D C Bloedow, F H Leffert
Research Communications in Chemical Pathology and Pharmacology|October 1, 1986
Meperidine disposition in burn patientsD C Bloedow, L A Goodfellow, J Marvin, et al.
Journal of Clinical Pharmacology|February 1, 1986
Postburn serum drug binding and serum protein concentrationsD C Bloedow, J F Hansbrough, T Hardin, et al.
Journal of Pharmaceutical Sciences|May 1, 1995
Kidney as a major clearance organ for recombinant human interleukin-1 receptor antagonistD C Kim, B Reitz, D F Carmichael, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|March 1, 1976
Effects of lipids on bioavailability of sulfisoxazole acetyl, dicumarol, and griseofulvin in ratsD C Bloedow, W L Hayton
Journal of Pharmaceutical Sciences|March 1, 1976
Saturable first-pass metabolism of sulfisoxazole N1-acetyl in ratsD C Bloedow, W L Hayton
Canadian Journal of Physiology and Pharmacology|August 1, 1979
Ketamine kinetics: decerebrate vs. intact catsJ E Heavner, D C Bloedow
The American Journal of Physiology|October 12, 1999
Pharmacokinetics of insulin-like growth factor I in hypopituitarism: correlation with binding proteinsN Mauras, V Quarmby, D C Bloedow
Research Communications in Chemical Pathology and Pharmacology|October 1, 1982
Serum binding of tocainide and its enantiomers in human subjectsA J Sedman, D C Bloedow, J Gal
Alcoholism, Clinical and Experimental Research|January 1, 1983
Nonlinear pharmacokinetics of ethanol elimination in long sleep and short sleep miceD M Gilliam, D C Bloedow, A C Collins
Journal of Pharmaceutical Sciences|November 1, 1981
Pharmacokinetics of intravenous chlorpheniramine in childrenJ A Thompson, D C Bloedow, F H Leffert
Research Communications in Chemical Pathology and Pharmacology|October 1, 1986
Meperidine disposition in burn patientsD C Bloedow, L A Goodfellow, J Marvin, et al.
Journal of Clinical Pharmacology|February 1, 1986
Postburn serum drug binding and serum protein concentrationsD C Bloedow, J F Hansbrough, T Hardin, et al.
Journal of Pharmaceutical Sciences|May 1, 1995
Kidney as a major clearance organ for recombinant human interleukin-1 receptor antagonistD C Kim, B Reitz, D F Carmichael, et al.
Pageof 4